Surrozen (NASDAQ:SRZN) Issues Quarterly Earnings Results

Surrozen (NASDAQ:SRZN) announced its quarterly earnings data on Monday. The company reported ($1.54) EPS for the quarter, beating analysts’ consensus estimates of ($2.79) by $1.25, Zacks reports.

Surrozen Stock Down 0.2 %

Surrozen stock traded down $0.01 during midday trading on Wednesday, reaching $6.55. The company’s stock had a trading volume of 32,601 shares, compared to its average volume of 13,443. The business has a 50-day simple moving average of $9.47 and a 200-day simple moving average of $10.53. Surrozen has a fifty-two week low of $4.50 and a fifty-two week high of $16.19.

About Surrozen

Surrozen, Inc, a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.